Aim of the Journal

The Journal of Lung Diseases and Pulmonary Medicine aims to serve as an international platform for the publication of high-quality research, clinical investigations, and scholarly contributions in the field of respiratory and pulmonary sciences. The journal is dedicated to advancing scientific understanding of lung diseases, improving diagnostic and therapeutic strategies, and promoting innovative research that contributes to better respiratory healthcare outcomes.

The journal seeks to bridge the gap between basic respiratory research and clinical practice by encouraging translational, interdisciplinary, and evidence-based studies related to pulmonary medicine, critical care, thoracic diseases, and respiratory therapeutics. It aims to support the development of advanced diagnostic methods, novel treatment approaches, preventive strategies, and personalized medicine for acute and chronic lung disorders.

The journal also strives to foster collaboration among pulmonologists, respiratory therapists, clinicians, researchers, academicians, healthcare professionals, and public health experts worldwide. Emphasis is placed on scientific rigor, ethical research practices, innovation, and dissemination of findings that have significant clinical and societal impact in respiratory medicine.

Scope of the Journal

The journal covers a broad range of topics related to pulmonary medicine, respiratory diseases, thoracic healthcare, and allied clinical and biomedical sciences. The primary areas of interest include, but are not limited to, the following:

Pulmonary medicine, respiratory medicine, clinical pulmonology, thoracic medicine, respiratory physiology, pulmonary pathology, pulmonary pharmacology, pulmonary rehabilitation, pulmonary diagnostics, respiratory therapeutics, critical care medicine, intensive care medicine, sleep medicine, respiratory infections, chronic obstructive pulmonary disease (COPD), asthma, bronchitis, emphysema, pneumonia, tuberculosis, interstitial lung diseases, pulmonary fibrosis, cystic fibrosis, bronchiectasis, pleural diseases, pulmonary hypertension, pulmonary embolism, occupational lung diseases, environmental lung diseases, allergic respiratory disorders, respiratory allergies, eosinophilic lung diseases, acute respiratory distress syndrome (ARDS), respiratory failure, lung cancer, thoracic oncology, mesothelioma, smoking-related lung diseases, vaping-associated lung injury, infectious lung diseases, viral respiratory infections, bacterial pneumonia, fungal lung infections, COVID-19 and post-COVID pulmonary complications, pediatric pulmonary diseases, neonatal respiratory disorders, geriatric pulmonary care, rare lung diseases, inherited respiratory disorders, respiratory immunology, pulmonary microbiology, molecular pulmonology, respiratory genetics, pulmonary biomarkers, lung imaging, chest radiology, thoracic imaging, bronchoscopy, pulmonary function testing, spirometry, respiratory monitoring, sleep apnea, sleep-disordered breathing, mechanical ventilation, non-invasive ventilation, extracorporeal membrane oxygenation (ECMO), thoracic surgery, lung transplantation, regenerative medicine in pulmonology, stem cell therapy for lung diseases, targeted therapy, immunotherapy in lung diseases, precision medicine, personalized respiratory care, pulmonary drug delivery systems, aerosol medicine, inhalation therapy, respiratory devices, oxygen therapy, respiratory nursing, physiotherapy in pulmonary care, pulmonary rehabilitation programs, epidemiology of respiratory diseases, public health pulmonology, global respiratory health, environmental pollution and lung health, occupational exposure and respiratory disease, tobacco control, smoking cessation, respiratory healthcare policy, health disparities in pulmonary care, telemedicine in respiratory care, artificial intelligence in pulmonary diagnostics, machine learning in respiratory medicine, bioinformatics in pulmonary research, clinical trials, translational respiratory research, and emerging technologies in pulmonary medicine.

Types of Manuscripts

The journal accepts a wide variety of manuscript types including original research articles, review articles, systematic reviews, meta-analyses, clinical studies, case reports, case series, short communications, technical notes, clinical images, perspectives, editorials, and letters to the editor.

The topics listed above represent the major areas of interest of the journal; however, the scope is not limited to these areas alone. The journal welcomes submissions from emerging, interdisciplinary, and innovative fields that contribute to the understanding, diagnosis, prevention, management, and treatment of lung diseases and respiratory disorders.

Global Perspective and Inclusivity

The journal adopts a global perspective by encouraging submissions from researchers, clinicians, and healthcare professionals across diverse geographic regions. Respiratory diseases remain a major global health burden, with prevalence and clinical outcomes varying across populations due to environmental, occupational, genetic, infectious, and socio-economic factors.

By promoting international collaboration, the journal seeks to address global respiratory health challenges and improve access to respiratory diagnosis, treatment, and preventive care. Studies highlighting regional disease patterns, population-specific findings, public health interventions, and global healthcare strategies are particularly encouraged.

Ethical, Legal, and Social Considerations

Research in pulmonary medicine and respiratory healthcare often involves important ethical and social considerations. The journal recognizes the importance of ethical clinical practice, patient safety, informed consent, data privacy, and equitable access to respiratory healthcare services.

Authors are expected to adhere to established ethical guidelines and ensure that their studies maintain the rights, dignity, confidentiality, and welfare of patients and research participants. Topics related to healthcare policy, respiratory health equity, environmental ethics, and access to advanced pulmonary care are also welcomed.

Education and Knowledge Dissemination

The journal is committed to advancing education and knowledge dissemination in the field of lung diseases and pulmonary medicine. It aims to serve as a valuable resource for students, educators, clinicians, researchers, respiratory therapists, and healthcare professionals by publishing informative, evidence-based, and clinically relevant content.

Educational reviews, clinical updates, practice guidelines, and articles that simplify complex respiratory concepts and provide practical insights into pulmonary care are strongly encouraged.

Quality, Integrity, and Scientific Rigor

Maintaining high standards of scientific quality and integrity is a central principle of the journal. All submissions are expected to demonstrate methodological soundness, originality, scientific rigor, and clarity of presentation.

The peer review process is designed to ensure thorough, fair, and unbiased evaluation of manuscripts. Authors are encouraged to present their findings transparently and accurately, thereby contributing to the reliability and credibility of respiratory and pulmonary scientific literature.

Encouragement of Collaborative Research

The journal promotes multidisciplinary and collaborative research involving pulmonologists, thoracic surgeons, intensivists, radiologists, pathologists, respiratory therapists, epidemiologists, molecular biologists, public health experts, and allied healthcare professionals.

Collaborative studies often provide broader insights and innovative solutions to complex respiratory disorders. Contributions resulting from national and international partnerships are highly encouraged.

Adaptability to Advancing Science

The field of pulmonary medicine is rapidly evolving with continuous advancements in diagnostics, therapeutics, digital health technologies, and respiratory research. The journal remains adaptable to these developments by expanding its scope to include emerging scientific areas and innovative treatment approaches.

Authors are encouraged to contribute novel concepts, advanced technologies, and translational research that enhance the understanding and management of respiratory diseases. The journal is committed to staying current with scientific progress and ensuring that its published content reflects the latest developments in lung disease research and pulmonary medicine.

The Journal of Lung Diseases and Pulmonary Medicine is committed to promoting excellence in respiratory research and clinical practice by maintaining a broad, inclusive, and interdisciplinary scope. By encouraging contributions from diverse scientific and medical disciplines, the journal aims to support scientific advancement and improve global healthcare outcomes in pulmonary medicine and respiratory health.